Baxter International Inc. [BAX] stock Downgrade by Goldman analyst, price target now $77


Baxter International Inc. [NYSE: BAX] slipped around -0.82 points on Thursday, while shares priced at $72.03 at the close of the session, down -1.13%. The company report on June 8, 2022 that Baxter to Host Second-Quarter 2022 Financial Results Conference Call for Investors.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2022 financial results on Thursday, July 28, 2022 at 7:30 a.m. Central Time. To participate in this conference call please follow this link to pre-register for the call and receive the call information.

This call is also being webcast and can be accessed through Baxter’s website at The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter’s permission.

Baxter International Inc. stock is now -16.09% down from its year-to-date (YTD) trading value. BAX Stock saw the intraday high of $72.85 and lowest of $71.50 per share. The company’s 52-week high price is 89.70, which means current price is +3.32% above from all time high which was touched on 02/09/22.

Compared to the average trading volume of 3.26M shares, BAX reached a trading volume of 2862050 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Baxter International Inc. [BAX]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BAX shares is $90.21 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BAX stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Goldman have made an estimate for Baxter International Inc. shares, keeping their opinion on the stock as Sell, with their previous recommendation back on April 04, 2022. While these analysts kept the previous recommendation, BofA Securities raised their target price to Buy. The new note on the price target was released on March 02, 2022, representing the official price target for Baxter International Inc. stock. Previously, the target price had yet another drop from $95 to $93, while Wells Fargo kept a Overweight rating on BAX stock. On February 18, 2022, analysts increased their price target for BAX shares from 88 to 91.

The Average True Range (ATR) for Baxter International Inc. is set at 1.65, with the Price to Sales ratio for BAX stock in the period of the last 12 months amounting to 2.74. The Price to Book ratio for the last quarter was 3.99, with the Price to Cash per share for the same quarter was set at 4.45. Price to Free Cash Flow for BAX in the course of the last twelve months was 46.64 with Quick ratio for the last quarter at 1.40.

How has BAX stock performed recently?

Baxter International Inc. [BAX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.00. With this latest performance, BAX shares dropped by -0.59% in over the last four-week period, additionally sinking by -10.64% over the last 6 months – not to mention a drop of -14.34% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BAX stock in for the last two-week period is set at 40.63, with the RSI for the last a single of trading hit 35.98, and the three-weeks RSI is set at 42.22 for Baxter International Inc. [BAX]. The present Moving Average for the last 50 days of trading for this stock 74.49, while it was recorded at 72.50 for the last single week of trading, and 79.99 for the last 200 days.

Baxter International Inc. [BAX]: Deeper insight into the fundamentals

Baxter International Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.40 and a Current Ratio set at 2.10.

Earnings analysis for Baxter International Inc. [BAX]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BAX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Baxter International Inc. go to 12.50%.

Insider trade positions for Baxter International Inc. [BAX]

There are presently around $31,431 million, or 88.80% of BAX stock, in the hands of institutional investors. The top three institutional holders of BAX stocks are: WELLINGTON MANAGEMENT GROUP LLP with ownership of 55,569,944, which is approximately 11.921% of the company’s market cap and around 0.20% of the total institutional ownership; BLACKROCK INC., holding 39,996,135 shares of the stock with an approximate value of $2.91 billion in BAX stocks shares; and VANGUARD GROUP INC, currently with $2.91 billion in BAX stock with ownership of nearly 2.431% of the company’s market capitalization.

474 institutional holders increased their position in Baxter International Inc. [NYSE:BAX] by around 32,884,513 shares. Additionally, 531 investors decreased positions by around 30,764,341 shares, while 256 investors held positions by with 367,803,011 shares. The mentioned changes placed institutional holdings at 431,451,865 shares, according to the latest SEC report filing. BAX stock had 107 new institutional investments in for a total of 4,431,898 shares, while 102 institutional investors sold positions of 2,924,261 shares during the same period.